Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Immunocore Holdings plc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 66 | 86 | +20 |
| Shares | 21.0M | 26.5M | +5.48M (+26.0%) |
| Value | $784.5M | $1.25B | +$461.7M (+58.9%) |
New holders (29)
Institutions that held Immunocore Holdings plc at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (9)
Institutions that held Immunocore Holdings plc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Bain Capital Public Equity Management II, LLC | 249,318 | $9.30M |
| OrbiMed Advisors LLC | 131,100 | $4.89M |
| Omega Fund Management, LLC | 51,535 | $1.92M |
| Waverton Investment Management Ltd | 27,330 | $1.02M |
| Schonfeld Strategic Advisors LLC | 25,200 | $940.0K |
| LMR Partners LLP | 15,000 | $560.0K |
| Pura Vida Investments, LLC | 6,419 | $239.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,864 | $144.0K |
| State of Wyoming | 215 | $8.00K |